Advances in disease biology: Therapeutic implications

被引：45
作者：
Anderson, KC
机构：
[1] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
来源：
SEMINARS IN HEMATOLOGY | 2001年 / 38卷 / 02期
关键词：
D O I：
10.1053/shem.2001.21065
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6 / 10
页数：5
相关论文
共 11 条
[1]  
[Anonymous], 1998, J Clin Oncol, V16, P3832
[2]   RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells [J].
Chauhan, D ;
Hideshima, T ;
Pandey, P ;
Treon, S ;
Teoh, G ;
Raje, N ;
Rosen, S ;
Krett, N ;
Husson, H ;
Avraham, S ;
Kharbanda, S ;
Anderson, KC .
ONCOGENE, 1999, 18 (48) :6733-6740
[3]   Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism [J].
Chauhan, D ;
Pandey, P ;
Ogata, A ;
Teoh, G ;
Treon, S ;
Urashima, M ;
Kharbanda, S ;
Anderson, KC .
ONCOGENE, 1997, 15 (07) :837-843
[4]   Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B [J].
Chauhan, D ;
Uchiyama, H ;
Akbarali, Y ;
Urashima, M ;
Yamamoto, K ;
Libermann, TA ;
Anderson, KC .
BLOOD, 1996, 87 (03) :1104-1112
[5]  
Chauhan D, 2000, J BIOL CHEM, V275, P27845
[6]   COMBINATION CHEMOTHERAPY VERSUS MELPHALAN AND PREDNISOLONE IN THE TREATMENT OF MULTIPLE-MYELOMA - AN OVERVIEW OF PUBLISHED TRIALS [J].
GREGORY, WM ;
RICHARDS, MA ;
MALPAS, JS .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (02) :334-342
[7]   Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy [J].
Hideshima, T ;
Chauhan, D ;
Shima, Y ;
Raje, N ;
Davies, FE ;
Tai, YT ;
Treon, SP ;
Lin, B ;
Schlossman, RL ;
Richardson, P ;
Muller, G ;
Stirling, DI ;
Anderson, KC .
BLOOD, 2000, 96 (09) :2943-2950
[8]   Cancer statistics, 1999 [J].
Landis, SH ;
Murray, T ;
Bolden, S ;
Wingo, PA .
CA-A CANCER JOURNAL FOR CLINICIANS, 1999, 49 (01) :8-31
[9]   Thalidomide - A revival story. [J].
Raje, N ;
Anderson, K .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (21) :1606-1609
[10]   Antitumor activity of thalidomide in refractory multiple myeloma. [J].
Singhal, S ;
Mehta, J ;
Desikan, R ;
Ayers, D ;
Roberson, P ;
Eddlemon, P ;
Munshi, N ;
Anaissie, E ;
Wilson, C ;
Dhodapkar, M ;
Zeldis, J ;
Barlogie, B ;
Siegel, D ;
Crowley, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (21) :1565-1571
12